Cases & Deals

ADOCIA initiates Level I ADR program in United States

Clients ADOCIA

Jones Day advised ADOCIA, a clinical-stage biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins, in connection with the implementation of its Level I American Depositary Receipt Program for the U.S. market with the Bank of New York Mellon on the OTC Markets.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.